Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer.
Salvatore PaiellaGabriele CapursoSilvia CarraraErica SecchettinFabio CascianiIsabella FrigerioAlessandro ZerbiLívia ArchibugiCristiana BonifacioGiuseppe MalleoGiulia Martina CavestroMonica BarileAlberto LarghiDaniela AssisiAlberto FantinAnna Caterina MilanettoCarlo FabbriRiccardo CasadeiGiulio DonatoRomano SassatelliGiulia De MarchiFrancesco Maria Di MatteoValentina ArcangeliFrancesco PanzutoMarta PuzzonoArianna Dal BuonoRaffaele PezzilliRoberto SalviaGianenrico RizzattiMarco CasadioMonica FrancoGiovanni ButturiniClaudio PasqualiChiara ColuccioClaudio RicciNoemi CiccheseGiuliana SereniNicolò de PretisSerena StiglianoBritt RudnasMatteo MarascoGabriella LionettoPaolo Giorgio ArcidiaconoMaria TerrinAnna CrovettoAlessandro MannucciLuigi LaghiClaudio BassiMassimo FalconiPublished in: The American journal of gastroenterology (2023)
PC surveillance in a fully public healthcare system is feasible, safe, and leads to early PC or pre-malignant lesions diagnoses, mostly at baseline but also over time.